Critical Care Doctor Slams Merck’s Anti-Covid Drug: ‘It Does Not Work’

EXCERPT:

KORY: "It’s because the way our system is designed. It’s designed to really put into play novel, patentable, high-profit pharmaceutical drugs. They weren’t ready in the beginning. So they had to suppress the evidence of early efficacy until such a time that those drugs could be introduced into the market. And those drugs were only introduced recently. And those drugs have serious problems. The Merck drug Molnupiravir does not work. We know it doesn’t work. The second half of the trial, placebo outperformed the drug. India just canceled their order for that drug. Paxlovid is the Pfizer drug. That one has very little safety data, we don't have long-term safety data on it. And that also has a lot of contraindications with other medications. And it also has toxicities, it's a scary drug."